Journal article

Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents


Authors listRingseis, R; Keller, J; Lukas, I; Spielmann, J; Most, E; Couturier, A; König, B; Hirche, F; Stangl, GI; Wen, GP; Eder, K

Publication year2013

Pages2105-2117

JournalBiochimica et Biophysica Acta (BBA) - General Subjects

Volume number1830

Issue number1

ISSN0304-4165

DOI Linkhttps://doi.org/10.1016/j.bbagen.2012.09.024

PublisherElsevier


Abstract

Background: Treatment of hyperlipidemic patients with fibrates, agonists of peroxisome proliferator-activated receptor alpha (PPAR alpha), provokes muscle atrophy as a side effect. The molecular mechanism underlying this phenomenon is still unknown. We tested the hypothesis that activation of PPAR alpha leads to an up-regulation of the ubiquitin proteasome system (UPS) which plays a major role in protein degradation in muscle.Methods: Rats, wild-type and PPAR alpha-deficient mice (PPAR alpha(-/-)) were treated with synthetic PPAR alpha agonists (clofibrate, WY-14,643) to study their effect on the UPS and myofibrillar protein breakdown in muscle.Results: In rats and wild-type mice but not PPAR alpha(-/-) mice, clofibrate or WY-14,643 caused increases in mRNA and protein levels of the ubiquitin ligases atrogin-1 and MuRF1 in muscle. Wild-type mice treated with WY-14,643 had a greater 3-methylhistidine release from incubated muscle and lesser muscle weights. In addition, wild-type mice but not PPAR alpha(-/-) mice treated with WY-14,643 had higher amounts of ubiquitin-protein conjugates, a decreased activity of PI3K/Akt1 signalling, and an increased activity of FoxO1 transcription factor in muscle. Reporter gene and gel shift experiments revealed that the atrogin-1 and MuRF1 promoter do not contain functional PPAR alpha DNA-binding sites.Conclusions: These findings indicate that fibrates stimulate ubiquitination of proteins in skeletal muscle which in turn stimulates protein degradation. Up-regulation of ubiquitin ligases is probably not mediated by PPAR alpha-dependent gene transcription but by PPAR alpha-dependent inhibition of the PI3K/Akt1 signalling pathway leading to activation of FoxO1.General significance: PPAR alpha plays a role in the regulation of the ubiquitin proteasome system.




Citation Styles

Harvard Citation styleRingseis, R., Keller, J., Lukas, I., Spielmann, J., Most, E., Couturier, A., et al. (2013) Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents, Biochimica et Biophysica Acta (BBA) - General Subjects, 1830(1), pp. 2105-2117. https://doi.org/10.1016/j.bbagen.2012.09.024

APA Citation styleRingseis, R., Keller, J., Lukas, I., Spielmann, J., Most, E., Couturier, A., König, B., Hirche, F., Stangl, G., Wen, G., & Eder, K. (2013). Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(1), 2105-2117. https://doi.org/10.1016/j.bbagen.2012.09.024


Last updated on 2025-21-05 at 16:02